Literature DB >> 952286

Providencia stuartii, a hospital pathogen: potential factors for its emergence and transmission.

R P Wenzel, K J Hunting, C A Osterman, M A Sande.   

Abstract

The emergence of Providencia stuartii as a hospital pathogen in a burn unit was demonstrated by routine infection surveillance. The organism was initially recognized in a burn wound and subsequently in urine or sputum. Compared to controls, those patients harboring P. stuartii were similar in age and percentage of body surface burned and were more likely to have been in one of the two burn unit rooms, (p less than 0.02). Infection with P. stuartii was independent of duration in the Intensive Care Unit or Burn Unit, and of number of visits to hydrotherapy or operating rooms (OR). Once patients were colonized with P. stuartii they had greater morbidity than non-colonized patients as evidenced by longer stays in the unit and increased visits to the OR for debridement. P. stuartii was isolated from air samples (5/14) more commonly than from the hands of personnel. In vitro tests suggested that extensive use of parenteral gentamicin and replacement of the antibacterial topical cream sulfamylon by silver sulfadiazine favored the emergence of P. stuartii over Pseudomonas aeruginosa as the predominant colonizing organism.

Entities:  

Mesh:

Year:  1976        PMID: 952286     DOI: 10.1093/oxfordjournals.aje.a112287

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.

Authors:  C Arpin; L Thabet; H Yassine; A A Messadi; J Boukadida; V Dubois; L Coulange-Mayonnove; C Andre; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

2.  Transferable urease activity in Providencia stuartii.

Authors:  R B Grant; J L Penner; J N Hennessy; B J Jackowski
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

3.  Prospective survey of fecal, urinary tract, and environmental colonization by Providencia stuartii in two geriatric wards.

Authors:  P M Hawkey; J L Penner; M R Potten; M Stephens; L J Barton; D C Speller
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

4.  Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria.

Authors:  J L Penner; G R Whiteley
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

5.  O serotyping of Providencia stuartii isolates collected from twelve hospitals.

Authors:  J L Penner; N A Hinton; I B Duncan; J N Hennessy; G R Whiteley
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

6.  Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.

Authors:  F E Kocka; S Srinivasan; M Mowjood; H S Kantor
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

7.  Genomic Analysis of two NDM-1 Providencia stuartii Strains Recovered from a Single Patient.

Authors:  Amparo Hoard; Sabrina Montaña; Alessandro Moriano; Jennifer S Fernandez; German M Traglia; Cecilia Quiroga; Agustina Franchi; Emilia Cohen; Cecilia Corigliano; Marisa Almuzara; Maria Soledad Ramirez
Journal:  Curr Microbiol       Date:  2020-10-13       Impact factor: 2.188

8.  Characterization of endemic Providencia stuartii isolates from patients with urinary devices.

Authors:  G E Hollick; F S Nolte; B J Calnan; J L Penner; L J Barton; A Spellacy
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  Differences among Providencia species in their in vitro susceptibilities to five antibiotics.

Authors:  J L Penner; M A Preston
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

10.  A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.

Authors:  B Prentice; B L Robinson
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.